Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DI1TY4
|
|||
Drug Name |
LY3041658
|
|||
Drug Type |
Monoclonal Antibody
|
|||
Indication | Hidradenitis suppurativa [ICD-11: ED92.0; ICD-10: L73.2] | Phase 2 | [1] | |
Company |
Lilly
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04493502) A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3041658 in Adults With Moderate-to-Severe Hidradenitis Suppurativa. U.S.National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.